What Is Triage?

Back To: Science Community Gives Mixed Reviews To 'Triage' The National Institutes of Health announced in the September 23 NIH Guide for Grants and Contracts that it will extend its use of a triage system to all investigator-initiated research grant (R01) and "FIRST Award" (First Independent Research Support and Transition Award, R29) applications submitted for October/November 1, 1994 receipt dates and reviewed by the NIH

Written byLiane Reif-lehrer
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The National Institutes of Health announced in the September 23 NIH Guide for Grants and Contracts that it will extend its use of a triage system to all investigator-initiated research grant (R01) and "FIRST Award" (First Independent Research Support and Transition Award, R29) applications submitted for October/November 1, 1994 receipt dates and reviewed by the NIH Division of Research Grants (DRG) at the February 1995 study-section meetings.

Under triage, R01 and R29 applications deemed by reviewers to be "noncompetitive" (NC) at current funding levels are not discussed at study-section meetings and are not routinely forwarded to the relevant advisory council, the second level of NIH peer review. To be categorized as NC, an application must be judged so by at least two assigned reviewers--but an application can be recalled for full review by even a single study-section member at any time before or during the meeting. Members are advised to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies